Track Tibet Rhodiola Pharmaceutical Holding Class A's goodwill ($81M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), 600211.SS shows a goodwill of $81M. That compares with $91M in the prior-year period — down 11.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 600211.SS's goodwill is now $81M (was $91M) — a 11.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Tibet Rhodiola Pharmaceutical Holding Class A is outperforming or lagging.
Tracking 600211.SS's goodwill over time shows whether Tibet Rhodiola Pharmaceutical Holding Class A is scaling, shrinking, or reshaping that part of the business. The current reading is $81M That compares with $91M in the prior-year period — down 11.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this goodwill page, Stockcircle has Tibet Rhodiola Pharmaceutical Holding Class A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $81M) with ownership activity and broader fundamentals.